A detailed history of Eagle Bay Advisors LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 96 shares of ILMN stock, worth $13,151. This represents 0.01% of its overall portfolio holdings.

Number of Shares
96
Previous 58 65.52%
Holding current value
$13,151
Previous $6,000 100.0%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$105.28 - $135.9 $4,000 - $5,164
38 Added 65.52%
96 $12,000
Q2 2024

Jul 26, 2024

SELL
$101.05 - $133.57 $8,084 - $10,685
-80 Reduced 57.97%
58 $6,000
Q1 2024

May 08, 2024

SELL
$127.73 - $147.2 $255 - $294
-2 Reduced 1.43%
138 $18,000
Q4 2023

Feb 08, 2024

BUY
$92.79 - $142.53 $8,629 - $13,255
93 Added 197.87%
140 $19,000
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $13,535 - $20,206
-105 Reduced 69.08%
47 $6,000
Q2 2023

Aug 10, 2023

SELL
$183.43 - $232.67 $11,922 - $15,123
-65 Reduced 29.95%
152 $28,000
Q1 2023

Apr 24, 2023

BUY
$193.75 - $232.55 $1,937 - $2,325
10 Added 4.83%
217 $50,000
Q4 2022

Jan 26, 2023

BUY
$187.24 - $242.74 $14,230 - $18,448
76 Added 58.02%
207 $0
Q3 2022

Nov 22, 2022

BUY
$177.23 - $227.44 $6,025 - $7,732
34 Added 35.05%
131 $25,000
Q2 2022

Aug 19, 2022

SELL
$181.58 - $368.0 $3,450 - $6,992
-19 Reduced 16.38%
97 $17.9 Million
Q1 2022

May 11, 2022

SELL
$303.87 - $423.8 $15,801 - $22,037
-52 Reduced 30.95%
116 $41,000
Q4 2021

Jan 21, 2022

BUY
$347.28 - $421.83 $26,045 - $31,637
75 Added 80.65%
168 $64,000
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $8,517 - $11,021
21 Added 29.17%
93 $37,000
Q2 2021

Jul 30, 2021

BUY
$372.84 - $481.5 $26,844 - $34,668
72 New
72 $35,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.